Patent · US Active

Dosage of a gluten peptide composition

US10449228B2 · kind B2 · utility

0Cited by
29References
21Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 10, 2014
Grant dateOct 22, 2019
Priority date—
Expiry dateSep 10, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/57
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods and compositions for treating subjects with Celiac disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.